tirasemtiv

DRUG2 trials

Sponsors

Cytokinetics

Conditions

Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis (ALS)

Phase 3

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

CompletedNCT02496767

CytokineticsAmyotrophic Lateral Sclerosis

Start: 2015-09-03End: 2017-09-27Updated: 2020-09-09

A Study for Patients Who Completed VITALITY-ALS (CY 4031)

CompletedNCT02936635

CytokineticsAmyotrophic Lateral Sclerosis (ALS)

Start: 2016-10-17End: 2018-10-26Updated: 2021-06-15

Related Papers

Plasma neurofilament analysis in VITALITY-ALS.

2024-11-082 citations

A phase III trial of <i>tirasemtiv</i> as a potential treatment for amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration2019-05-1344 citations

VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics.

2018-02-0622 citations